Inactive Instrument
Quotes Celsion Corporation Nasdaq
Stocks
US15117N3052
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 24/09 | IMUNON, Inc. Presents Update On IMNN-001 Development Program For Women With Newly Diagnosed Advanced Ovarian Cancer | CI |
| 24/09 | Imunon, Inc. - Shareholder/Analyst Call |
Stock exchange
Basic data
Market Cap (USD)
5,639,460
Net sales (USD)
0
Free-Float
93.73%
Free-Float capitalization (USD)
5,285,650
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 5.64M | |
| -0.21% | -6.36% | +49.00% | +74.13% | 66.34B | |
| -0.22% | +6.53% | +11.68% | +90.35% | 52.92B | |
| +0.82% | +5.41% | +8.05% | +74.45% | 54.82B | |
| +2.12% | +5.05% | +25.87% | +49.82% | 44.09B | |
| +0.50% | +9.82% | +22.25% | +128.76% | 43.72B | |
| -0.14% | +1.43% | +266.95% | +969.35% | 42.13B | |
| +0.10% | +9.96% | +17.15% | +59.33% | 33.96B | |
| -1.30% | -3.61% | +37.37% | +7.16% | 26.17B | |
| +0.69% | +5.60% | +36.60% | +26.39% | 23.37B | |
| Average | +0.22% | +4.78% | +52.77% | +164.42% | 38.75B | |
| Weighted average by Cap. | +0.24% | +4.67% | +51.83% | +168.42% |
Historical Quotes: Celsion Corporation
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- IMNN Stock
- Stock
- Quotes Celsion Corporation
Select your edition
All financial news and data tailored to specific country editions
